Drug application
TRANSDERM-NITRO (NITROGLYCERIN)
Drugs@FDA NDA 020144 · NOVARTIS
Key facts
| Drug name | TRANSDERM-NITRO |
|---|---|
| Active ingredients | NITROGLYCERIN |
| Application type | NDA |
| Application number | 020144 |
| Company | NOVARTIS |
| Dosage forms | FILM, EXTENDED RELEASE, TRANSDERMAL |
| Strength | 0.1MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission status date | Oct 19, 1981 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.